Search Results

Displaying Results 2226-2250 of 8089 "'III'"

Jun 11, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against ServBanc Holdco, Inc., ServBank, National Association, IF Bancorp, Inc., and its Board of Directors - IROQ

and Special Dividend were misleading insofar as they overstated the likelihood that IF Bancorp shareholders would receive the Special Dividend; and (iii) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable

More news about: Pomerantz LLP


Jun 11, 2026, 09:35 ET SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 4, 2026 in Grail, Inc. Lawsuit - GRAL

Begin: February 2026 ReassessmentWhen Grail disclosed on February 19, 2026, that the "primary endpoint of statistically significant Stage III-IV reduction was not observed," the analyst consensus fractured overnight. Coverage that had been anchored to confidence in the three-year trial design

More news about: SueWallSt.com


Jun 11, 2026, 09:00 ET Abbott recebe aprovação para dois novos biossimilares no Brasil, ampliando o acesso ao tratamento da osteoporose e de complicações ósseas relacionadas ao câncer

osteoporose.2Além disso, ela é uma das principais causas de mortalidade entre idosos e afeta particularmente as mulheres na pós-menopausa. O estudo de Fase III, SIMBA, conduzido pela mAbxience e publicado na revista Pharmaceutics (2026), confirmou que o biossimilar MB09 comercializado pela Abbott

More news about: Abbott


Jun 11, 2026, 09:00 ET MORE THAN 50 LEADERS AND ORGANIZATIONS JOIN NATIONAL LEADERSHIP COUNCIL TO LAUNCH "BE THE PEOPLE" - A 10-YEAR EFFORT TO REIGNITE THE AMERICAN SPIRIT

Demario Davis, and Brian Grazer; Thought Leaders like Tim Shriver, John Bridgeland, Emma Bloomberg, Arthur C. Brooks, Danielle Allen, Martin Luther King III, Yuval Levin, and Todd Rose; Faith Leaders like Bishop T.D. Jakes and Dr. DeForest B. Soaries, Jr.; Philanthropic Leaders from Stand Together, the Ford

More news about: Be The People


Jun 11, 2026, 09:00 ET Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement

America and preparation for potential future commercialization of the Co-Dx PCR platform, subject to applicable regulatory review and authorization; and (iii) that the flexibility and rapid response capability of the Company's high-quality PCR technology will become increasingly important in global diagnostics

More news about: Co-Diagnostics


Jun 11, 2026, 08:45 ET RBLX INVESTORS: Robbins Geller Rudman & Dowd LLP Announces that Roblox Corporation Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

while continuing to be "enormously bullish" on their tech rollouts as well as claiming to be able to "rely on [their] tremendous organic growth"; and (iii) Roblox relied far too heavily on viral events to drive growth and failed to communicate to investors the potential knock-on impacts of the age verification

More news about: Robbins Geller Rudman & Dowd LLP


Jun 11, 2026, 08:11 ET Oncura Health Physicians Recognized for Research Contributions at ASCO 2026

named contributor on a poster presentation titled "Achieving epidemiologically representative enrollment and social determinants of health in the Phase III EVeRA Breast Cancer Study."This research underscores the importance of improving clinical trial access and representation to ensure advancements

More news about: Oncura Health


Jun 11, 2026, 07:45 ET SoCalGas Helps Customers Save More Than $106 Million Through Energy Efficiency Programs

(i) negotiating pricing and other terms in definitive contracts, (ii) completing construction projects or other transactions on schedule and budget, (iii) realizing anticipated benefits from any of these efforts if completed, (iv) obtaining regulatory and other approvals and (v) third parties honoring

More news about: Southern California Gas Co.


Jun 11, 2026, 07:17 ET Natural Grocers® Celebrates New Mexico Day with a Special Gift and Savings June 14-16, 2026

details via {N}power email or app. Must present phone number at checkout to accumulate towards the minimum requirement in one transaction.[iii] Sign up by 6/12/2026 to receive this coupon via email or app. {N}power offers are available only to registered members and are subject to program

More news about: Natural Grocers by Vitamin Cottage, Inc.


Jun 11, 2026, 06:30 ET GRAL INVESTOR ALERT: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

reduction in Stage III-IV cancers in Grail's NHS-Galleri trial, while also concealing material adverse facts which reduced the possibility of such an outcome; (ii) in truth, Grail's optimism in achieving the primary endpoint of its NHS-Galleri study fell short of reality; and (iii) the confidence management

More news about: Robbins Geller Rudman & Dowd LLP


Jun 11, 2026, 05:36 ET Gum Arabic Market Gains Momentum as Clean-Label Ingredient Demand Accelerates | CAGR 6.3% | Persistence Market Research

Saffron Market by Grade (Grade I, Grade II, Grade III, Grade IV), Form (Stigma, Powder, Liquid, Petals, Stamen), Application (Food & Beverages, Pharmaceuticals, Cosmetics & Personal Care), Distribution

More news about: Persistence Market Research Pvt. Ltd.


Jun 11, 2026, 02:20 ET CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) ASCO 2026 Key Highlights

development advantage.October 2026: Discuss the Phase III global registrational clinical trial protocol for first-line NSCLC + chemotherapy (vs. pembrolizumab + chemotherapy) .Q4 2026: Discuss the Phase III global registrational clinical trial protocol for first-line mCRC + chemotherapy

More news about: CStone Pharmaceuticals


Jun 11, 2026, 00:15 ET Annonce des accords de licence et de fourniture de Zemcelpro® (thérapie cellulaire UM171) pour le Canada

génétiques, les patients nécessitant une deuxième greffe, ainsi que les patients présentant une maladie réfractaire ou active. Un essai clinique de phase III déterminant sera lancé dès que possible auprès de cette population de patients.L'utilisation de Zemcelpro® chez d'autres populations

More news about: ExCellThera


Jun 10, 2026, 20:59 ET GlycoNex Announces Positive Topline Results for Phase III Clinical Trial of Denosumab Biosimilar SPD8

June 10, 2026 /PRNewswire/ -- GlycoNex, Inc. (4168, hereinafter referred to as GNX), today announced that the Phase III clinical trial for SPD8, a Denosumab biosimilar co-developed with Mitsubishi Gas Chemical, has successfully met its primary endpoint. Statistical analysis

More news about: GlycoNex, Inc.


Jun 10, 2026, 17:12 ET Haivision Announces Results for the Three Months and Six Months Ended April 30, 2026

to certain (i) non-IFRS financial measures, including "EBITDA", and "Adjusted EBITDA", (ii) non-IFRS ratios including "Adjusted EBITDA Margin", and (iii) supplementary financial measures including "Gross Margins" (collectively "non-IFRS measures"). These non-IFRS measures are not recognized measures

More news about: Haivision Systems Inc.


Jun 10, 2026, 16:05 ET M3-Brigade Acquisition V Corp. Announces Postponement of Extraordinary General Meeting of Shareholders to Approve Business Combination and Extension of Redemption Deadline

materials filed or that will be filed with the SEC. Information regarding the directors and executive officers of the Company is set forth in (i) Part III, Item 10. Directors, Executive Officers and Corporate Governance of the Company's Annual Report on Form 10-K and (ii) the Company's Current Reports on

More news about: M3-Brigade Acquisition V Corp.


Jun 10, 2026, 16:02 ET Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

Contact:Donald T. Gardner III704/871-3274

More news about: Kewaunee Scientific Corporation


Jun 10, 2026, 15:00 ET Bitmine Immersion Technologies (BMNR) 宣佈其以太幣持有量達 554 萬枚代幣,加密資產及現金總持有額達 96 億美元

Bitmine 為美國第 148 大最活躍交易股票,日均成交額達 8.29 億美元(5 日平均)Bitmine 持續獲得頂級機構投資者支持,包括 ARK 的 Cathie Wood、MOZAYYX、Founders Fund、Bill Miller III、Pantera、Kraken、DCG、Galaxy Digital 以及個人投資者 Thomas "Tom" Lee,攜手支持 Bitmine 收購 5% 以太幣的目標康州諾沃克2026年6月11日

More news about: Bitmine Immersion Technologies, Inc.


Jun 10, 2026, 14:52 ET BitMine Immersion Technologies (BMNR) anuncia que as participações de ETH atingem 5,54 milhões de tokens, e o total de criptomoedas e o total de liquidez em caixa são de US$ 9,6 bilhões

A BitMine continua apoiada por um grupo de investidores institucionais de destaque, incluindo Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e o investidor pessoal Thomas "Tom" Lee, para apoiar a meta da BitMine de adquirir 5% do ETHNORWALK,

More news about: Bitmine Immersion Technologies, Inc.


Jun 10, 2026, 14:46 ET Bitmine Immersion Technologies (BMNR) anuncia que sus tenencias de ETH alcanzan los 5,54 millones de tokens y que sus tenencias totales de criptomonedas y efectivo ascienden a 9,6 mil millones de dólares

respaldo de un grupo de inversionistas institucionales de primer nivel, entre los que se encuentran Cathie Wood de ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital y el inversionista particular Thomas "Tom" Lee, con el fin de apoyar el objetivo de Bitmine de adquirir el 5 %

More news about: Bitmine Immersion Technologies, Inc.


Jun 10, 2026, 14:32 ET Bitmine Immersion Technologies (BMNR) annuncia che le partecipazioni in ETH raggiungono i 5,54 milioni di token, mentre le partecipazioni totali in criptovalute e contanti ammontano a 9,6 miliardi di dollari

continua a essere sostenuta da un gruppo di investitori istituzionali di prim'ordine tra cui ARK di Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital e l'investitore privato Thomas "Tom" Lee a sostegno dell'obiettivo di Bitmine di acquisire il 5% di ETH

More news about: Bitmine Immersion Technologies, Inc.


Jun 10, 2026, 12:22 ET Program Announcement for Annual ASPC Congress on CVD Prevention, July 2026

FoundationNanette Wenger Award: Dr. Samia Mora, Harvard Medical School / Brigham and Women's HospitalJoseph Stokes III, MD Pioneer in Prevention Award: Dr. Keith Ferdinand, Tulane UniversityCongress Chair"The ASPC Congress is the premier annual

More news about: The American Society for Preventive Cardiology


Jun 10, 2026, 10:19 ET Einride, a Global Leader in Autonomous and Electric Freight, Commences Trading on Nasdaq Under Tickers "ENRD" and "ENRDW"

for the future of freight that is backed by a decade of disciplined execution," added Eric Rosenfeld, former Chief SPAC Officer of Legato Merger Corp. III ("Legato") and a director of Einride. "We are proud to have partnered with the Einride team to bring this transformative opportunity to the public markets."Investor

More news about: Einride


Jun 10, 2026, 10:14 ET Einride, a Global Leader in Autonomous and Electric Freight, Commences Trading on Nasdaq Under Tickers "ENRD" and "ENRDW"

for the future of freight that is backed by a decade of disciplined execution," added Eric Rosenfeld, former Chief SPAC Officer of Legato Merger Corp. III ("Legato") and a director of Einride. "We are proud to have partnered with the Einride team to bring this transformative opportunity to the public markets."Investor

More news about: Einride


Jun 10, 2026, 10:01 ET Developmental and Epileptic Encephalopathies Market to Register Immense Growth at a CAGR of 11.7% During the Forecast Period (2026-2036) Due to the Launch of Next-Generation Gene and Targeted Therapies | DelveInsight

orphan drug designation from both the FDA and EMA, along with rare pediatric disease designation from the FDA, and is currently being assessed in Phase III clinical trials for patients with Dravet syndrome.Longboard Pharmaceuticals' Bexicaserin is an orally administered, centrally acting 5-HT2C

More news about: DelveInsight Business Research, LLP


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.